Literature DB >> 6685570

Cerebrospinal fluid-platinum kinetics of cisplatin in man.

J P Armand, J P Macquet, A F LeRoy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6685570

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  6 in total

1.  Neural stem/progenitors and glioma stem-like cells have differential sensitivity to chemotherapy.

Authors:  Xing Gong; Philip H Schwartz; Mark E Linskey; Daniela A Bota
Journal:  Neurology       Date:  2011-02-23       Impact factor: 9.910

2.  Cerebrospinal fluid concentrations of carboplatin in a patient without blood-brain barrier disruption.

Authors:  V Brunner; P Houyau; E Chatelut; H Roché; P Canal
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

3.  Direct delivery of platinum-based antineoplastics to the central nervous system: a toxicity and ultrastructural study.

Authors:  A Olivi; M Gilbert; K L Duncan; B Corden; D Lenartz; H Brem
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

4.  Distribution of cisplatin in perilymph and cerebrospinal fluid after intravenous administration in the guinea pig.

Authors:  G Laurell; A Andersson; B Engström; H Ehrsson
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

5.  cis-diamminedichloroplatinum (CDDP) therapy for brain metastasis of lung cancer. I. Distribution within the central nervous system after intravenous and intracarotid infusion.

Authors:  H Nakagawa; T Fujita; S Izumoto; S Kubo; Y Nakajima; K Tsuruzono; K Kodama; M Higashiyama; O Doi; T Hayakawa
Journal:  J Neurooncol       Date:  1993-04       Impact factor: 4.130

6.  Cerebral herniation in patients receiving cisplatin.

Authors:  R W Walker; J G Cairncross; J B Posner
Journal:  J Neurooncol       Date:  1988       Impact factor: 4.130
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.